Publications by authors named "Phillip Febbo"

Claim this Profile
P
Prevalence of Potential Candidates for Targeted Therapies According to Treatment-related Transcriptomic Signatures Among 140 548 Patients with Nonmetastatic Prostate Cancer.
Nicole Handa, Eric V Li, Jamie Michael, James A Proudfoot, Adam B Weiner, Phillip G Febbo

Eur Urol Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editor's Note: Androgen-Induced Differentiation and Tumorigenicity of Human Prostate Epithelial Cells.
Raanan Berger, Phillip G Febbo, Pradip K Majumder, Jean J Zhao, Shayan Mukherjee

Cancer Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progression.
Meng Zhang, Martin Sjöström, Xiekui Cui, Adam Foye, Kyle Farh, Phillip G Febbo

Nat Cell Biol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer Care.
Phillip G Febbo, Mina Allo, Emma B Alme, Gebra Cuyun Carter, Robert Dumanois

JCO Precis Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance).
Andrew B Nixon, Susan Halabi, Yingmiao Liu, Mark D Starr, John C Brady, Phillip G Febbo

Clin Cancer Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States.
Nicole L Washington, Karthik Gangavarapu, Mark Zeller, Alexandre Bolze, Elizabeth T Cirulli, Phillip G Febbo

Cell· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic epidemiology identifies emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States.
Nicole L Washington, Karthik Gangavarapu, Mark Zeller, Alexandre Bolze, Elizabeth T Cirulli, Phillip G Febbo

medRxiv· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The DNA methylation landscape of advanced prostate cancer.
Shuang G Zhao, William S Chen, Haolong Li, Adam Foye, Meng Zhang, Phillip Febbo

Nat Genet· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases.
Phillip G Febbo, Anne-Marie Martin, Howard I Scher, J Carl Barrett, Julia A Beaver

Clin Pharmacol Ther· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 17-Gene Genomic Prostate Score Assay Predicts Outcome After Radical Prostatectomy Independent of PTEN Status.
Cristina Magi-Galluzzi, Sudhir Isharwal, Sara M Falzarano, Athanasios Tsiatis, Anne Dee, Phillip G Febbo

Urology· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 17-Gene Genomic Prostate Score Assay Provides Independent Information on Adverse Pathology in the Setting of Combined Multiparametric Magnetic Resonance Imaging Fusion Targeted and Systematic Prostate Biopsy.
Amirali Salmasi, Jonathan Said, Alan W Shindel, Pooria Khoshnoodi, Ely R Felker, Phillip G Febbo

J Urol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the 16-Gene Recurrence Score in Patients with Locoregional, High-Risk Renal Cell Carcinoma from a Phase III Trial of Adjuvant Sunitinib.
Brian I Rini, Bernard Escudier, Jean-Francois Martini, Ahmed Magheli, Christer Svedman, Phillip G Febbo

Clin Cancer Res· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease.
Stephen K Van Den Eeden, Ruixiao Lu, Nan Zhang, Charles P Quesenberry, Jun Shan, Phillip G Febbo

Eur Urol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving risk stratification among veterans diagnosed with prostate cancer: impact of the 17-gene prostate score assay.
Julie A Lynch, Megan P Rothney, Raoul R Salup, Cesar E Ercole, Sharad C Mathur, Phillip G Febbo

Am J Manag Care· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Balancing Confounding and Generalizability Using Observational, Real-world Data: 17-gene Genomic Prostate Score Assay Effect on Active Surveillance.
Steven Canfield, Michael J Kemeter, Phillip G Febbo, John Hornberger

Rev Urol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between a 17-gene genomic prostate score and multi-parametric prostate MRI in men with low and intermediate risk prostate cancer (PCa).
Michael S Leapman, Antonio C Westphalen, Niloufar Ameli, H Jeffrey Lawrence, Phillip G Febbo

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of a 17-Gene Prognostic Assay in Contemporary Urologic Practice: Results of an Interim Analysis in an Observational Cohort.
Gregg Eure, Raymond Germany, Robert Given, Ruixiao Lu, Alan W Shindel, Phillip G Febbo

Urology· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying Health Information Technology Needs of Oncologists to Facilitate the Adoption of Genomic Medicine: Recommendations From the 2016 American Society of Clinical Oncology Omics and Precision Oncology Workshop.
Kevin S Hughes, Edward P Ambinder, Gregory P Hess, Peter Paul Yu, Elmer V Bernstam, Phillip G Febbo

J Clin Oncol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active Surveillance Use Among a Low-risk Prostate Cancer Population in a Large US Payer System: 17-Gene Genomic Prostate Score Versus Other Risk Stratification Methods.
Steven Canfield, Michael J Kemeter, John Hornberger, Phillip G Febbo

Rev Urol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.
Daniel L Hertz, Kouros Owzar, Sherrie Lessans, Claudia Wing, Chen Jiang, Phillip G Febbo

Clin Cancer Res· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression in normal-appearing tissue adjacent to prostate cancers are predictive of clinical outcome: evidence for a biologically meaningful field effect.
Cristina Magi-Galluzzi, Tara Maddala, Sara Moscovita Falzarano, Diana B Cherbavaz, Nan Zhang, Phillip G Febbo

Oncotarget· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate Score.
Timothy C Brand, Nan Zhang, Michael R Crager, Tara Maddala, Anne Dee, Phillip G Febbo

Urology· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health Economic Impact and Prospective Clinical Utility of Oncotype DX® Genomic Prostate Score.
David Albala, Michael J Kemeter, Phillip G Febbo, Ruixiao Lu, Vincy John

Rev Urol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of the Oncotype DX Prostate Cancer Assay in Clinical Practice for Treatment Selection in Men Newly Diagnosed with Prostate Cancer: A Retrospective Chart Review Analysis.
Marc A Dall'Era, Tara Maddala, Louise Polychronopoulos, Jack R Gallagher, Phillip G Febbo

Urol Pract· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of a Biopsy Based 17-Gene Genomic Prostate Score on Treatment Recommendations in Men with Newly Diagnosed Clinically Prostate Cancer Who are Candidates for Active Surveillance.
Ketan K Badani, Michael J Kemeter, Phillip G Febbo, H Jeffrey Lawrence, Béla S Denes

Urol Pract· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis